LRRK2 and Parkinson disease: In addition, and with respect to the LRRK2 gene, D. melanogaster mutants that overlap significant features with the human condition have boosted several studies in PD research because of their alternative strategies for disease treatment [24,25,26] by means of both mutants’ gain-of-function and loss-of-function kinase 2 domains [27,28,29].